How to Help Your Patients Find CellCept in Stock: A Provider's Guide

As a transplant physician, nephrologist, or transplant coordinator, you've likely fielded increasingly frequent calls from patients who can't fill their CellCept (mycophenolate mofetil) prescription. Generic supply disruptions have made this a recurrent problem in 2026 — and for transplant recipients, an empty pill bottle isn't just an inconvenience. It's a rejection risk.

This guide provides concrete strategies your practice can use to reduce the frequency of these calls and help patients resolve supply issues quickly when they do occur.

Strategy 1: Default to Specialty Pharmacy Routing

Retail chain pharmacies are disproportionately affected by generic drug supply disruptions. Specialty pharmacies serving transplant programs maintain more reliable inventory of immunosuppressants as a core part of their business model.

Best practice: At the time of transplant, actively route all transplant patients to a designated specialty pharmacy partner. Ensure your transplant coordinator has a direct contact at that pharmacy for urgent situations. Revisit this routing at annual follow-up appointments.

Strategy 2: Prescribe 90-Day Fills for Stable Patients

For stable transplant patients in the maintenance phase, 90-day supplies dramatically reduce the frequency of refill transactions and the associated stock-out risk. A patient filling a 30-day supply faces the shortage problem four times per year; a patient on a 90-day fill faces it once.

Many commercial insurance plans require mail-order for 90-day fills of maintenance medications after a certain number of 30-day fills. Educate patients about their mail-order pharmacy option and encourage them to transition before they have a supply crisis.

Strategy 3: Write 'Brand Medically Necessary' When Appropriate

Brand CellCept (Genentech) is generally available when generics are not. For patients who are calling because their generic is out of stock, writing a prescription specifying 'brand medically necessary' immediately opens access to a better-stocked product.

Cost consideration: The Genentech co-pay card reduces brand CellCept co-pays to as little as $15/month for commercially insured patients, with up to $10,000 in annual benefit. For uninsured or government-insured patients, the Genentech Access to Care Foundation (GATCF) may provide medication at no cost after an application process.

Strategy 4: Educate Patients on Refill Timing

Many pharmacy-level shortage crises happen because patients wait until the last pill before refilling. By the time the pharmacy orders the medication, receives it, and processes the prescription, the patient has already missed doses.

Include refill timing in your transplant education: instruct patients to begin the refill process at least 10–14 days before their current supply runs out. Consider including this as a point in your discharge paperwork and annual medication counseling.

Strategy 5: Use medfinder to Locate Stock Near Your Patients

When a patient calls reporting that their pharmacy is out of stock, your care team can use medfinder for providers to check pharmacies near the patient without spending staff time on hold. medfinder calls pharmacies and provides real-time stock results — it covers all medications, including CellCept and generic mycophenolate.

Your transplant coordinators can recommend this directly to patients who are struggling to find their medication, reducing the volume of inbound calls to your practice.

Strategy 6: Prepare a Shortage Protocol Document

Having a written, pre-approved shortage protocol in your practice prevents ad hoc decision-making when patients call in distress. The protocol should include:

Step 1: Verify the specific formulation and strength that's unavailable

Step 2: Attempt to locate the same formulation at a different pharmacy (use medfinder or direct patient to specialty pharmacy)

Step 3: If unavailable locally, issue brand CellCept prescription with 'brand medically necessary'

Step 4: If brand is also unavailable, consider approved alternative formulation (Myfortic with dose conversion) — requires physician review

Step 5: If supply cannot be obtained within 24–48 hours, escalate to attending physician for clinical decision on antiproliferative alternatives

Resources for Your Practice and Your Patients

ASHP Drug Shortage Database (ashp.org/drug-shortages) — current shortage status and manufacturer information

Genentech co-pay card (cellcept.com) — reduces brand CellCept to $15/month for commercially insured patients

Genentech Access to Care Foundation (GATCF) — for uninsured or coverage-denied patients

medfinder for providers — real-time pharmacy inventory search by medication and location